In the continued fight against the virus that causes COVID-19, we have seen how important monoclonal antibodies and other therapeutics are in helping prevent serious illness. As viral variants arise and spread, it is increasingly critical that healthcare providers who care for people at increased risk of developing severe COVID-19 symptoms have the latest treatment information at their fingertips. During this webinar on Thursday, September 9, 3:00-4:00 pm ET, Dr. Michael Anderson with the HHS Office of the Assistant Secretary for Preparedness and Response will share the latest information on the available COVID-19 therapeutics and address important updates such as the efficacy of the medications, new administration routes and novel treatments in the pipeline, fee reimbursement resources, provider and patient tools and fact sheets, and much more. Dr. Anderson will also be available for a Q&A to answer providers’ questions about these important COVID-19 therapies.
This webinar will include the local perspective as we are joined by NYC Department of Health and Mental Hygiene. We will hear about some of the challenges and solutions in the education, promotion, and coordination of therapeutics. Additionally, NYC will share resources that have been developed to support their recent activities.
This webinar is open to all members of local health departments as well as other community partners who are interested in this topic. Only registered participants will be able to join. Register here.